生物
诱导多能干细胞
移植
胰岛素
干细胞
细胞生物学
体外
细胞疗法
细胞
细胞分化
分泌物
内科学
内分泌学
癌症研究
胚胎干细胞
生物化学
医学
基因
作者
Felicia W. Pagliuca,Jeffrey R. Millman,Mads Gürtler,Michael Segel,Alana Van Dervort,Jennifer Hyoje Ryu,Quinn P. Peterson,Dale L. Greiner,Douglas A. Melton
出处
期刊:Cell
[Elsevier]
日期:2014-10-01
卷期号:159 (2): 428-439
被引量:1757
标识
DOI:10.1016/j.cell.2014.09.040
摘要
The generation of insulin-producing pancreatic β cells from stem cells in vitro would provide an unprecedented cell source for drug discovery and cell transplantation therapy in diabetes. However, insulin-producing cells previously generated from human pluripotent stem cells (hPSC) lack many functional characteristics of bona fide β cells. Here, we report a scalable differentiation protocol that can generate hundreds of millions of glucose-responsive β cells from hPSC in vitro. These stem-cell-derived β cells (SC-β) express markers found in mature β cells, flux Ca2+ in response to glucose, package insulin into secretory granules, and secrete quantities of insulin comparable to adult β cells in response to multiple sequential glucose challenges in vitro. Furthermore, these cells secrete human insulin into the serum of mice shortly after transplantation in a glucose-regulated manner, and transplantation of these cells ameliorates hyperglycemia in diabetic mice.
科研通智能强力驱动
Strongly Powered by AbleSci AI